Irbesartan tablets approved by FDA
-
Last Update: 2020-04-03
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
Haizheng Pharmaceutical (600267) announced in the evening of Friday (June 24) that the new drug of irbesartan tablets of Haizheng Pharmaceutical (Hangzhou) Co., Ltd., a wholly-owned subsidiary of the company, has been approved by the US FDA Irbesartan is an antagonist of Ang Ⅱ receptor, which is mainly used in the treatment of hypertension Haizheng pharmaceutical said that the approval of Anda of irbesartan tablets by the US FDA marks that the company has the qualification to sell the product in the US market, which has a positive impact on the company's expansion of the US market Announcement of Zhejiang Haizheng Pharmaceutical Co., Ltd on the approval of irbesartan tablets by FDA
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
